Krill oil is “the fastest growing ingredient in the whole omega-3 market”, Canadian krill oil firm Neptune Technologies & Bioressources has claimed after unveiling its preliminary results for the first quarter of fiscal 2013.
Canadian krill oil firm Neptune Technologies & Bioressources has posted a 31% surge in sales in its nutraceutical business in the final quarter of fiscal 2012, and a 15% rise in sales in this division over the full year.
Construction of a new factory that will manufacture Neptune Technologies & Bioressources’ krill oil products in Asia, will begin late this year or early next, and start generating revenue in 2014, bosses at the Canadian firm have revealed.
Canadian krill oil firm Neptune Technologies & Bioressources has posted a 20% rise in third-quarter revenues to $5.12m in its nutraceuticals business and a $869,000 net profit compared with a $13,000 loss for the same period the previous year.
Canadian krill oil firm Neptune Technologies & Bioressources has begun the first phase of an expansion project at its facility in Sherbrooke, Québec that will see production double to 300,000kg of Neptune Krill Oil (NKO) per year.
Canadian krill oil firm Neptune Technologies & Bioressources aims to ratchet up production capacity from 130,000kg/year to almost 500,000kg by 2014 to meet growing demand.
Neptune Technologies & Bioressources has reported increased
sales for its second quarter, as the firm continues development
work with Nestle and Yoplait on its flagship krill oil product.
Neptune Technologies and Bioressources has entered into a
collaborative agreement with the Nestle Research Centre that will
pave the way towards Neptune Krill Oil's use in range of functional
foods.
Enzymotec has announced its entry into the krill oil market, going
head to head with market leader Neptune Krill Oil and planning
clinical research into the health benefits of its ingredient.
Neptune Technologies & Bioressources's efforts to spread the
word about Neptune Krill Oil and an internal reorganisation are
paying off, as the Canadian manufacturer has reported a significant
increase in sales and a decrease...
Neptune Technologies & Bioressources is currently designing a
large scale cognitive study on its proprietary Neptune Krill Oil,
following positive results in a recent clinical study on the
marine-derived ingredient and adult ADHD.
Neptune Technologies & Bioressources has announced the closing
of a $4.5mn private placement of common shares, which is designed
to help accelerate its business strategy and boost R&D efforts.
Neptune Technologies and Bioressources is planning a private
placement of common shares that will raise between C$3m and $4.5m
to help accelerate its business strategy and boost R&D efforts.
Neptune Technologies and Bioressources is eyeing the path towards
profitability after a full year 2005 in which it increased sales of
ingredient from marine biomasses by 45 per cent and slashed
operating losses by 50 per cent, compared...
Neptune Technologies and Bioressources has entered into an alliance
with Germany's Degussa over two projects that will facilitate the
use of its krill oil and potent derivatives in nutraceuticals and
foods.
Canadian firm Neptune Technologies & Bioressources is to market
its Neptune Krill Oil in the US. The product will be sold through
the Vitamin World chain and distributed by NBTY's Nature's Bounty.
Canadian company Neptune Technologies and Bioressources said that
interim data from clinical trials of its Neptune Krill Oil show
that it is effective in treating both the physical and
psychological effects of premenstrual syndrome.
